Rickard Kathleen A. 4
4 · Verona Pharma plc · Filed May 8, 2025
Insider Transaction Report
Form 4
Rickard Kathleen A.
Chief Medical Officer
Transactions
- Sale
Ordinary Shares
2025-05-06$8.82/sh−114,984$1,014,343→ 2,546,472 total
Footnotes (4)
- [F1]Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- [F2]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted on December 11, 2024.
- [F3]The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $8.675 to $9.015 per Ordinary Share, inclusive (or $69.4 to $72.12 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- [F4]Consists of (i) 659,984 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 82,498 ADSs); and (ii) 1,886,488 Ordinary Shares underlying 235,811 ADSs.